Results for Audentes

Add to feed Create your own feed

Latest

$ALPMF #Astellas  Pharma Inc. Astellas Pharma Inc.: Update following rating review for downgrade: Our credit view of Astellas, reflecting its increase in leverage as a result of the Audentes acquisition. #credit 

tweet picture

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Audentes Therapeutics, Inc. – BOLD

Audentes Therapeutics downgraded to neutral from overweight at J.P. Morgan #news 

Loading
Loading

Most relevant

Japan's Astellas to buy Audentes for $3 billion in gene therapy push

tweet picture

Audentes Therapeutics' stock rockets 106% to record high after Astellas Pharma buyout deal

everybody wants to buy gene therapies Astellas snags gene therapy upstart Audentes with $3B bid, with plans for more deals to come $BOLD +106%

Astellas to acquire Audentes for $60 per share in cash $ALPMY $BOLD

Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics $BOLD

Piper believes Audentes could be targeting DMD with AT720 $BOLD $SRPT

BREAKING: Shares of Audentes Therapeutics up 5.8 percent, Bluebird Bio up 4.9 percent, Pacira Pharmaceuticals up 3.1 percent

tweet picture

S.F.'s Audentes Therapeutics sets IPO price targets, hopes to raise up to $… BiotechSF blog

Loading
Loading